A. Cimadamore, A. Rizzo, V. Mollica, F. Massari, A. López-Beltran, M. Scarpelli, Liang Cheng, M. Santoni, R. Montironi
{"title":"肿瘤免疫治疗进展","authors":"A. Cimadamore, A. Rizzo, V. Mollica, F. Massari, A. López-Beltran, M. Scarpelli, Liang Cheng, M. Santoni, R. Montironi","doi":"10.1080/23808993.2021.1911638","DOIUrl":null,"url":null,"abstract":"Section of Pathological Anatomy, Polytechnic University of the Marche Region, School of Medicine, United Hospitals, Ancona, Italy; Division of Oncology, IRCCS Azienda Ospedaliero-Universitaria Di Bologna, Bologna, Italy; Department of Surgery, Cordoba University Medical School, Cordoba, Spain; Department of Pathology and Laboratory Medicine, Indiana University School of Medicine, Indianapolis, USA; Oncology department, Macerata Hospital, Macerata, Italy","PeriodicalId":12124,"journal":{"name":"Expert Review of Precision Medicine and Drug Development","volume":"6 1","pages":"229 - 233"},"PeriodicalIF":1.0000,"publicationDate":"2021-05-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1080/23808993.2021.1911638","citationCount":"2","resultStr":"{\"title\":\"An update on immunotherapy in uro-oncology\",\"authors\":\"A. Cimadamore, A. Rizzo, V. Mollica, F. Massari, A. López-Beltran, M. Scarpelli, Liang Cheng, M. Santoni, R. Montironi\",\"doi\":\"10.1080/23808993.2021.1911638\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Section of Pathological Anatomy, Polytechnic University of the Marche Region, School of Medicine, United Hospitals, Ancona, Italy; Division of Oncology, IRCCS Azienda Ospedaliero-Universitaria Di Bologna, Bologna, Italy; Department of Surgery, Cordoba University Medical School, Cordoba, Spain; Department of Pathology and Laboratory Medicine, Indiana University School of Medicine, Indianapolis, USA; Oncology department, Macerata Hospital, Macerata, Italy\",\"PeriodicalId\":12124,\"journal\":{\"name\":\"Expert Review of Precision Medicine and Drug Development\",\"volume\":\"6 1\",\"pages\":\"229 - 233\"},\"PeriodicalIF\":1.0000,\"publicationDate\":\"2021-05-03\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.1080/23808993.2021.1911638\",\"citationCount\":\"2\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Expert Review of Precision Medicine and Drug Development\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1080/23808993.2021.1911638\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"PHARMACOLOGY & PHARMACY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Expert Review of Precision Medicine and Drug Development","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1080/23808993.2021.1911638","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
Section of Pathological Anatomy, Polytechnic University of the Marche Region, School of Medicine, United Hospitals, Ancona, Italy; Division of Oncology, IRCCS Azienda Ospedaliero-Universitaria Di Bologna, Bologna, Italy; Department of Surgery, Cordoba University Medical School, Cordoba, Spain; Department of Pathology and Laboratory Medicine, Indiana University School of Medicine, Indianapolis, USA; Oncology department, Macerata Hospital, Macerata, Italy
期刊介绍:
Expert Review of Precision Medicine and Drug Development publishes primarily review articles covering the development and clinical application of medicine to be used in a personalized therapy setting; in addition, the journal also publishes original research and commentary-style articles. In an era where medicine is recognizing that a one-size-fits-all approach is not always appropriate, it has become necessary to identify patients responsive to treatments and treat patient populations using a tailored approach. Areas covered include: Development and application of drugs targeted to specific genotypes and populations, as well as advanced diagnostic technologies and significant biomarkers that aid in this. Clinical trials and case studies within personalized therapy and drug development. Screening, prediction and prevention of disease, prediction of adverse events, treatment monitoring, effects of metabolomics and microbiomics on treatment. Secondary population research, genome-wide association studies, disease–gene association studies, personal genome technologies. Ethical and cost–benefit issues, the impact to healthcare and business infrastructure, and regulatory issues.